Clinical Trials Browser

Phase 2 × Carcinoma, Hepatocellular × LY-2157299 × Clear all

NCT02178358 2022-02-25

A Study of LY2157299 in Participants With Advanced Hepatocellular Carcinoma

Phase 2 Completed

132 enrolled 25 charts

Gastrointestinal

Camurati-Engelmann Syndrome, Carcinoma, Hepatocellular

NCT01246986 2021-01-12

A Study of LY2157299 in Participants With Hepatocellular Carcinoma

Phase 2 Completed

204 enrolled 27 charts

Gastrointestinal

Carcinoma, Hepatocellular